The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode

https://doi.org/10.1016/j.bmcl.2013.05.047Get rights and content

Abstract

A novel series of p38 MAP kinase inhibitors with high selectivity for the p38α isoform over the other family members including the highly homologous p38β isoform has been identified. X-ray co-crystallographic studies have revealed an unprecedented kinase binding mode in p38α for representative analogs, 5c and 9d, in which a Leu108/Met109 peptide flip occurs within the p38α hinge region. Based on these findings, a general strategy for the rational design of additional promising p38α isoform selective inhibitors by targeting this novel binding mode is proposed.

References and notes (19)

  • M.I. Davis et al.

    Nat. Biotechnol.

    (2011)
  • S.T. Wrobleski et al.

    Curr. Top. Med. Chem.

    (2005)
    L.H. Pettus et al.

    Curr. Top. Med. Chem.

    (2008)
  • For experimental conditions for biochemical assays, please see Hynes, J.; Wu, Hong; Leftheris, K.; Liu, C.; Das, J.;...
  • F.T. Burling et al.

    J. Am. Chem. Soc.

    (1992)
    M. Iwaoko et al.

    J. Am. Chem. Soc.

    (2002)
  • G. Manning et al.

    Science

    (2002)
  • P. Cohen

    Nat. Rev. Drug Disc.

    (2002)
    P. Cohen

    Curr. Opin. Cell Biol.

    (2009)
  • J.C. Lee et al.

    Nature

    (1994)
    S. Kumar et al.

    Nat. Rev. Drug Disc.

    (2003)
  • D.M. Goldstein et al.

    Curr. Top. Med. Chem.

    (2005)
There are more references available in the full text version of this article.

Cited by (0)

View full text